Encision Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Encision Inc. with three other
companies in this sector in the United States:
Advansource Biomaterials Corporation
sales of $2.28 million
Repro-Med Systems, Inc.
Sonoma Pharmaceuticals Inc
of which 100%
was Drugs & Devices).
Encision Inc. reported sales of $8.87 million
March of 2017.
decrease of 5.0%
versus 2016, when the company's sales were $9.34 million.